building innovation capabilities at nhrd
TRANSCRIPT
Honing innovation capabilities: Leadership
and Culture
Pavan SoniInnovation Evangelist and
Researcher [email protected]
www.pavansoni.com
What are capabilities?
Repeatability | Reliability | Embedded | Purposeful | Coordinated
How capabilities come into being
05/03/2023 Pavan Soni, Innovation Evangelist 3
Products Services Processes Customers …
Processes People Culture
Leadership Founder/ Entrepreneur
Business Model Institutions
Formal | Informal
Environment Munificence | Dynamism | Complexity
Creating a stretch “Developing capital-intensive premium products through disruptively innovative process engineering that could deliver affordable pricing and make a difference to global healthcare.”
- Kiran Mazumdar-Shaw, Founder and CMD, Biocon Ltd.
1978- Enzymes (solid substrate fermentation)
1996- Statins using
fermentation
2007- Enters Biosimilars
Exits enzymes biz.
2003- Insulin (Pichia expression system)
2004- INSUGEN®(rh-insulin)2006- BIOMAb-EGFR™(Nimotuzumab), India’s first anti-cancer drug 2009- BASALOG®(Glargine) 2013- ALZUMAb™(Itolizumab), a 'first in class' anti-CD6 monoclonal antibody2014- CANMAb™ (Trastuzumab)
05/03/2023 Pavan Soni, Innovation Evangelist 4
2006- Launches Biocon
Biopharmaceuticals
2009- Tie-up with Mylan for
Biosimilars
World-leading research on Oral Insulin
Leadership
Sensing and shaping opportunities
05/03/2023 Pavan Soni, Innovation Evangelist 5
“To be a discovery-led global pharmaceutical company.”
- Anji K Reddy, Founder, Dr. Reddy’s Lab
1984- DRL develops APIs (Methyldopa)
1980-84- Uniloids, Standard Organics
1986- Formulations, Enters US market
1991- First to enter Russia and Soviet block
1993- First to set-up discovery research
1996- Forms biotechnology division
1997- First to co-license to Novo Nordisk
2001- Enters US generics
2008- Sets up Speciality Pharma/ Complex
Generics
Discovery- centricity
Patient- centricityCost- centricity
Leadership
State of perpetual crisis
05/03/2023 Pavan Soni, Innovation Evangelist 6
“We want to beat Sony by 2005!”- Eric Kim, Head of Marketing, Samsung (2001)
“Change everything, except your wife and kids.”- Lee Kun-hee, Chairman, Samsung
Public burning of over 100,000 cordless phones at Samsung Gumi factory on March 9, 1995
Paradoxes that drive Samsung: Size and speed Diversified but specialized Japanese and American management styles combined
Innovation through Bold investments Being the fast
follower Co-opetition Owner-led
transformation
Leadership
As a leader
05/03/2023 Pavan Soni, Innovation Evangelist 7
Leadership
Creating a stretch Setting impossible goals Maintaining a state of
perpetual crisis Sensing and shaping
opportunities
Variation and selection
05/03/2023 Pavan Soni, Innovation Evangelist 8
Great Ideas are born at the Intersection of Disciplines- Frans Johansson
Discovering Intersections
Operating Engineer Model (1994) Diploma holders 25% built-in attrition 80+% of shop floor- 50+ plants Systemic innovation
Leadership embraces failure Operational autonomy Non pharma scientists in IPDOSelf Managed Teams (2001)
Culture
Operational autonomy and financial accountability
05/03/2023 Pavan Soni, Innovation Evangelist 9
Culture
“We believe that any significant growth requires investment, and, very often, the growth that we see is linked to the level of investment that we make. A challenge, though a tough one, is to manage the conflict of investing in building the future without diluting the current results.”
- Azim H Premji, Chairman of Wipro Ltd.
Stage Gate Model of R&D funding (2001)
Quantum Innovations (2006)
Technology Themes (2008)
Centers of Excellence (1996)
Practice Framework (2002)
Point Solutions (2003)
Let a million flowers blossom
Enabling improvisation
05/03/2023 Pavan Soni, Innovation Evangelist 10
Culture
On the culture
05/03/2023 Pavan Soni, Innovation Evangelist 11
Culture
Introducing variation and selection
Operational autonomy and financial accountability
An innovation anchor Focus on innovation culture,
not outcome Enabling improvisation
In summary
05/03/2023 Pavan Soni, Innovation Evangelist 12
Introducing variation and selection
Operational autonomy and financial accountability
An innovation anchor Focus on innovation
culture, not outcome Enabling improvisation
Culture Leadership
Creating a stretch Setting impossible
goals Maintaining a state of
perpetual crisis Sensing and shaping
opportunities